The percentage of adults with cancer in the US who used gabapentinoids for long-term pain control increased from 2.3% in 2005 to 5.6% in 2015, according to a study in the journal Supportive Care in Cancer. A growing need for chronic pain therapy among cancer survivors and the opioid crisis may explain the trend, said researcher Alex Fauer, who noted prescribers should educate patients and caregivers about the risks of using gabapentinoids.
More US adults with cancer use gabapentinoids for pain control
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.